AR050913A1 - Compuestos derivados de tiazolpiridina como activadores de glucoquinasa; composiciones farmaceuticas que los contienen y su uso en medicamentos para el tratamiento de la diabetes tipo ii - Google Patents
Compuestos derivados de tiazolpiridina como activadores de glucoquinasa; composiciones farmaceuticas que los contienen y su uso en medicamentos para el tratamiento de la diabetes tipo iiInfo
- Publication number
- AR050913A1 AR050913A1 ARP050103320A ARP050103320A AR050913A1 AR 050913 A1 AR050913 A1 AR 050913A1 AR P050103320 A ARP050103320 A AR P050103320A AR P050103320 A ARP050103320 A AR P050103320A AR 050913 A1 AR050913 A1 AR 050913A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- hydrogen
- cycloalkyl
- attached form
- alkylene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Estos compuestos son activadores de la actividad de glucocinasa y, de esta manera, pueden ser empleados como agentes terapéuticos para el tratamiento de condiciones mediadas por glucocinasa. Por consiguiente, los compuestos de la formula (1) pueden ser empleados para la prevencion y el tratamiento de tolerancia danada a glucosa, diabetes de tipo 2 y obesidad. Reivindicacion 1: Un compuesto de la formula (1), en donde: R1 es hidrogeno, halogeno, ciano, nitro, alquilo opcionalmente sustituido, alcoxi, alquiltio, alquiltiono, sulfonilo, carboxi, carbamoilo, sulfamoilo o amino opcionalmente sustituidos; R2 es cicloalquilo C3-6 o heterociclilo C3-6; R3 es hidrogeno, halogeno, ciano, alquilo inferior o alcoxi inferior; R4 es hidrogeno, alquilo opcionalmente sustituido, o cicloalquilo; o R5 es -(CR6R7)m-W-R8, en donde, R6 y R7 son independientemente hidrogeno, alquilo opcionalmente sustituido o cicloalquilo; o R6 y R7 combinados son alquileno que junto con el átomo de carbono al cual están unidos forman un anillo de 3 a 7 miembros; m es cero o un entero de 1 a 5; W es -NR9- en donde R9 es hidrogeno, alquilo opcionalmente sustituido o heterociclilo; o R9 es -C(O)R10, -C(O)OR10, o -C(O)NR10R11, en donde, R10 es alquilo opcionalmente sustituido, cicloalquilo, arilo, heteroarilo, aralquilo o heteroaralquilo; R11 es hidrogeno o alquilo inferior; o R11 y R10 combinados son alquileno junto con el átomo de carbono a los cuales están unidos forman un anillo de 4 a 7 miembros; o W está ausente; R8 es hidrogeno, alquilo C1-7 opcionalmente sustituido, cicloalquilo, arilo o heterociclilo; o R8 y R9 combinados son alquileno que junto con el átomo de nitrogeno al cual están unidos forman un anillo de 4 a 7 miembros; o R5 y R4 combinados son alquileno que junto con el átomo de nitrogeno al cual están unidos forman un anillo de 4 a 7 miembros; o R5 y R4 tomados juntos con el átomo de nitrogeno al cual están unidos forman un anillo fusionado, en puente o bicíclico espiral de 6 a 12 miembros, el cual puede estar opcionalmente sustituido o puede contener de 1 a 3 átomo heterogéneos distintos seleccionados de oxígeno, nitrogeno y azufre; o un enantiomero del mismo; o una mezcla enantiomérica del mismo, o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55918404P | 2004-04-02 | 2004-04-02 | |
PCT/EP2005/003456 WO2005095418A1 (en) | 2004-04-02 | 2005-04-01 | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
AR050913A1 true AR050913A1 (es) | 2006-12-06 |
Family
ID=34963913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050103320A AR050913A1 (es) | 2004-04-02 | 2005-08-09 | Compuestos derivados de tiazolpiridina como activadores de glucoquinasa; composiciones farmaceuticas que los contienen y su uso en medicamentos para el tratamiento de la diabetes tipo ii |
Country Status (19)
Country | Link |
---|---|
US (1) | US7750020B2 (es) |
EP (1) | EP1735322B1 (es) |
JP (1) | JP4700684B2 (es) |
KR (1) | KR100830007B1 (es) |
CN (1) | CN1960995B (es) |
AR (1) | AR050913A1 (es) |
AT (1) | ATE524479T1 (es) |
AU (1) | AU2005229416B2 (es) |
BR (1) | BRPI0509573A (es) |
CA (1) | CA2560689C (es) |
EC (1) | ECSP066894A (es) |
IL (1) | IL178151A0 (es) |
MA (1) | MA28528B1 (es) |
NO (1) | NO20064929L (es) |
PE (1) | PE20061353A1 (es) |
PT (1) | PT1735322E (es) |
RU (1) | RU2412192C2 (es) |
TN (1) | TNSN06315A1 (es) |
WO (1) | WO2005095418A1 (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
WO2004050645A1 (en) | 2002-10-03 | 2004-06-17 | Novartis Ag | Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
EP1737870A1 (en) * | 2004-04-02 | 2007-01-03 | Novartis AG | Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
TW200630337A (en) | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
GT200600429A (es) * | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
GT200600428A (es) | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
CA2627813A1 (en) * | 2005-11-01 | 2007-05-10 | Janssen Pharmaceutica N.V. | Substituted pyrrolones as allosteric modulators of glucokinase |
CA2627910A1 (en) * | 2005-11-01 | 2007-05-10 | Janssen Pharmaceutica N.V. | Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
CA2627892A1 (en) | 2005-11-01 | 2007-05-10 | Janssen Pharmaceutica N.V. | Substituted dihydroisoindolones as allosteric modulators of glucokinase |
US7531671B2 (en) * | 2005-11-01 | 2009-05-12 | Janssen Pharmaceutica N.V. | Dihydroisoindolones as allosteric modulators of glucokinase |
WO2007110449A1 (en) | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
TW200815353A (en) | 2006-04-13 | 2008-04-01 | Euro Celtique Sa | Benzenesulfonamide compounds and their use |
US8937181B2 (en) | 2006-04-13 | 2015-01-20 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
EP2046755A2 (en) | 2006-07-24 | 2009-04-15 | F. Hoffmann-Roche AG | Pyrazoles as glucokinase activators |
TW200831081A (en) | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
BRPI0808267A2 (pt) * | 2007-03-07 | 2014-07-22 | Kyorin Phamaceutical Co., Ltd | "composto representado pela formula geral (1) ou um sal farmeceuticamente aceitável do mesmo; método para o tratamento ou prevenção de diabetes ; uso do composto; composição farmacêutica e composto representado pela formula geral (3)". |
WO2008119734A2 (en) * | 2007-03-29 | 2008-10-09 | Novartis Ag | Process for the manufacture of organic compounds |
US8399486B2 (en) | 2007-04-09 | 2013-03-19 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use thereof |
US8765736B2 (en) | 2007-09-28 | 2014-07-01 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
CN101827832B (zh) * | 2007-10-08 | 2014-05-07 | 阿德维纳斯治疗私人有限公司 | 作为葡糖激酶活化剂的乙酰胺衍生物、其制备方法及医药应用 |
CN101417987B (zh) * | 2007-10-24 | 2011-07-13 | 山东轩竹医药科技有限公司 | 具有磺酰胺甲酰哌嗪结构的dpp-iv抑制剂 |
TW200942239A (en) | 2008-01-18 | 2009-10-16 | Astellas Pharma Inc | Phenylacetamide derivatives |
US8258134B2 (en) | 2008-04-16 | 2012-09-04 | Hoffmann-La Roche Inc. | Pyridazinone glucokinase activators |
US7741327B2 (en) | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
CA2722733C (en) | 2008-04-28 | 2016-02-23 | Kyorin Pharmaceutical Co., Ltd. | Cyclopentylacrylamide derivative |
BRPI0912802A2 (pt) | 2008-05-16 | 2015-10-13 | Takeda San Diego Inc | ativadores de glicoquinase |
EP2344458A1 (en) | 2008-09-11 | 2011-07-20 | Pfizer Inc. | Heteroaryls amide derivatives and their use as glucokinase activators |
EA018894B1 (ru) | 2009-03-11 | 2013-11-29 | Пфайзер Инк. | N,n-диметил-5-(2-метил-6-((5-метилпиразин-2-ил)карбамоил)бензо-фуран-4-илокси)пиримидин-2-карбоксамид, используемый в качестве активатора глюкокиназы, и содержащая его фармацев-тическая композиция |
US8765747B2 (en) | 2009-06-12 | 2014-07-01 | Dana-Farber Cancer Institute, Inc. | Fused 2-aminothiazole compounds |
US8222416B2 (en) | 2009-12-14 | 2012-07-17 | Hoffmann-La Roche Inc. | Azaindole glucokinase activators |
EP2519517B1 (en) | 2009-12-29 | 2015-03-25 | Dana-Farber Cancer Institute, Inc. | Type ii raf kinase inhibitors |
EP3936608A1 (en) | 2010-03-31 | 2022-01-12 | The Scripps Research Institute | Reprogramming cells |
EP2822935B1 (en) | 2011-11-17 | 2019-05-15 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-jun-n-terminal kinase (jnk) |
WO2013173382A1 (en) * | 2012-05-15 | 2013-11-21 | Amgen Inc. | Benzothiophene sulfonamides and other compounds that interact with glucokinase regulatory protein |
EP2909194A1 (en) | 2012-10-18 | 2015-08-26 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
WO2014063061A1 (en) | 2012-10-19 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
US10000483B2 (en) | 2012-10-19 | 2018-06-19 | Dana-Farber Cancer Institute, Inc. | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof |
EP3057956B1 (en) | 2013-10-18 | 2021-05-05 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7) |
US20160264551A1 (en) | 2013-10-18 | 2016-09-15 | Syros Pharmaceuticals, Inc. | Heteroaromatic compounds useful for the treatment of prolferative diseases |
WO2015164614A1 (en) | 2014-04-23 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Janus kinase inhibitors and uses thereof |
WO2015164604A1 (en) | 2014-04-23 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
WO2016105528A2 (en) | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
US10550121B2 (en) | 2015-03-27 | 2020-02-04 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
WO2016201370A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
EP4019515A1 (en) | 2015-09-09 | 2022-06-29 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2242469C2 (ru) * | 1999-03-29 | 2004-12-20 | Ф.Хоффманн-Ля Рош Аг | Активаторы глюкокиназы |
US6320050B1 (en) * | 1999-03-29 | 2001-11-20 | Hoffmann-La Roche Inc. | Heteroaromatic glucokinase activators |
US6610846B1 (en) | 1999-03-29 | 2003-08-26 | Hoffman-La Roche Inc. | Heteroaromatic glucokinase activators |
DK1169312T3 (da) | 1999-03-29 | 2005-01-31 | Hoffmann La Roche | Glucokinaseaktivatorer |
US6353111B1 (en) | 1999-12-15 | 2002-03-05 | Hoffmann-La Roche Inc. | Trans olefinic glucokinase activators |
AU7049401A (en) * | 2000-05-03 | 2001-11-12 | Hoffmann La Roche | Alkynyl phenyl heteroaromatic glucokinase activators |
BR0110492A (pt) * | 2000-05-03 | 2003-04-08 | Hoffmann La Roche | Composto, composição farmacêutica que compreende esse composto, processo para a preparação de composição farmacêutica, utilização do composto e processo para a preparação do composto |
DE60106599T2 (de) * | 2000-05-08 | 2006-02-09 | F. Hoffmann-La Roche Ag | Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren |
WO2001085707A1 (en) | 2000-05-08 | 2001-11-15 | F. Hoffmann-La Roche Ag | Para-amine substituted phenylamide glucokinase activators |
US6489485B2 (en) * | 2000-05-08 | 2002-12-03 | Hoffmann-La Roche Inc. | Para-amine substituted phenylamide glucokinase activators |
WO2002008209A1 (en) | 2000-07-20 | 2002-01-31 | F. Hoffmann-La Roche Ag | Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
US6369232B1 (en) * | 2000-08-15 | 2002-04-09 | Hoffmann-La Roche Inc. | Tetrazolyl-phenyl acetamide glucokinase activators |
US6433188B1 (en) * | 2000-12-06 | 2002-08-13 | Wendy Lea Corbett | Fused heteroaromatic glucokinase activators |
PT1341774E (pt) * | 2000-12-06 | 2006-05-31 | Hoffmann La Roche | Activadores heteroaromaticos, fundidos de glicocinase |
US6482951B2 (en) | 2000-12-13 | 2002-11-19 | Hoffmann-La Roche Inc. | Isoindolin-1-one glucokinase activators |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
US6911545B2 (en) | 2001-12-19 | 2005-06-28 | Hoffman-La Roche Inc. | Crystals of glucokinase and methods of growing them |
BR0215212A (pt) | 2001-12-21 | 2004-12-07 | Novo Nordisk As | Ativador de carboxamida ou sulfonamida de glicoquinase, composto, composição farmacêutica, e, uso de um composto |
JP4419571B2 (ja) * | 2002-03-26 | 2010-02-24 | 萬有製薬株式会社 | 新規アミノベンズアミド誘導体 |
JP4091600B2 (ja) | 2002-04-26 | 2008-05-28 | エフ.ホフマン−ラ ロシュ アーゲー | 置換フェニルアセトアミド及びグルコキナーゼ活性化物質としてのその使用 |
JPWO2003097824A1 (ja) | 2002-05-16 | 2005-09-15 | 萬有製薬株式会社 | グルコキナーゼタンパク質の結晶、及びその結晶を用いたドラッグデザイン方法 |
KR101116627B1 (ko) | 2002-06-27 | 2012-10-09 | 노보 노르디스크 에이/에스 | 치료제로서 아릴 카르보닐 유도체 |
WO2004050645A1 (en) * | 2002-10-03 | 2004-06-17 | Novartis Ag | Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
WO2004031179A1 (en) | 2002-10-03 | 2004-04-15 | F. Hoffmann-La Roche Ag | Indole-3-carboxamides as glucokinase (gk) activators |
MY141521A (en) | 2002-12-12 | 2010-05-14 | Hoffmann La Roche | 5-substituted-six-membered heteroaromatic glucokinase activators |
ES2362656T3 (es) | 2003-01-06 | 2011-07-11 | Eli Lilly And Company | Arilciclopropilacetamidas sustituidas como activadores de glucoquinasa. |
WO2004063194A1 (en) | 2003-01-06 | 2004-07-29 | Eli Lilly And Company | Heteroaryl compounds |
PL378117A1 (pl) | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
WO2004072066A1 (en) | 2003-02-11 | 2004-08-26 | Prosidion Limited | Tri(cyclo) substituted amide glucokinase activator compounds |
NZ540791A (en) | 2003-02-13 | 2009-09-25 | Banyu Pharma Co Ltd | Novel 2-pyridinecarboxamide derivatives |
MXPA05009059A (es) | 2003-02-26 | 2005-10-19 | Banyu Pharma Co Ltd | Derivados de heteroarilcarbamoilbenceno. |
EP1737870A1 (en) * | 2004-04-02 | 2007-01-03 | Novartis AG | Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
JP2007533722A (ja) | 2004-04-21 | 2007-11-22 | プロシディオン・リミテッド | トリ(シクロ)置換アミド化合物 |
MX2007001650A (es) | 2004-08-12 | 2007-07-13 | Prosidion Ltd | Fenilacetamidas substituidas y su uso como activadores de glucocinasa. |
CA2590720A1 (en) | 2004-12-03 | 2006-06-08 | Lone Jeppesen | Heteroaromatic glucokinase activators |
GT200600428A (es) | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
GT200600429A (es) | 2005-09-30 | 2007-04-30 | Compuestos organicos |
-
2005
- 2005-04-01 JP JP2007505512A patent/JP4700684B2/ja not_active Expired - Fee Related
- 2005-04-01 CN CN2005800178910A patent/CN1960995B/zh not_active Expired - Fee Related
- 2005-04-01 AT AT05731007T patent/ATE524479T1/de not_active IP Right Cessation
- 2005-04-01 BR BRPI0509573-5A patent/BRPI0509573A/pt not_active IP Right Cessation
- 2005-04-01 KR KR1020067020441A patent/KR100830007B1/ko not_active IP Right Cessation
- 2005-04-01 EP EP05731007A patent/EP1735322B1/en active Active
- 2005-04-01 PT PT05731007T patent/PT1735322E/pt unknown
- 2005-04-01 AU AU2005229416A patent/AU2005229416B2/en not_active Ceased
- 2005-04-01 CA CA2560689A patent/CA2560689C/en not_active Expired - Fee Related
- 2005-04-01 US US11/547,046 patent/US7750020B2/en not_active Expired - Fee Related
- 2005-04-01 WO PCT/EP2005/003456 patent/WO2005095418A1/en active Application Filing
- 2005-04-01 RU RU2006138433/04A patent/RU2412192C2/ru not_active IP Right Cessation
- 2005-08-09 AR ARP050103320A patent/AR050913A1/es not_active Application Discontinuation
-
2006
- 2006-03-29 PE PE2006000347A patent/PE20061353A1/es not_active Application Discontinuation
- 2006-09-18 IL IL178151A patent/IL178151A0/en unknown
- 2006-09-29 TN TNP2006000315A patent/TNSN06315A1/en unknown
- 2006-09-29 EC EC2006006894A patent/ECSP066894A/es unknown
- 2006-10-11 MA MA29381A patent/MA28528B1/fr unknown
- 2006-10-27 NO NO20064929A patent/NO20064929L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MA28528B1 (fr) | 2007-04-03 |
CN1960995B (zh) | 2010-12-08 |
AU2005229416B2 (en) | 2009-03-26 |
CA2560689A1 (en) | 2005-10-13 |
TNSN06315A1 (en) | 2007-12-03 |
BRPI0509573A (pt) | 2007-09-25 |
US20080103167A1 (en) | 2008-05-01 |
WO2005095418A1 (en) | 2005-10-13 |
PE20061353A1 (es) | 2006-12-29 |
EP1735322A1 (en) | 2006-12-27 |
ATE524479T1 (de) | 2011-09-15 |
AU2005229416A1 (en) | 2005-10-13 |
KR20060131955A (ko) | 2006-12-20 |
JP4700684B2 (ja) | 2011-06-15 |
NO20064929L (no) | 2006-12-20 |
JP2007530632A (ja) | 2007-11-01 |
US7750020B2 (en) | 2010-07-06 |
CN1960995A (zh) | 2007-05-09 |
EP1735322B1 (en) | 2011-09-14 |
CA2560689C (en) | 2011-03-01 |
IL178151A0 (en) | 2006-12-31 |
PT1735322E (pt) | 2012-01-12 |
RU2412192C2 (ru) | 2011-02-20 |
ECSP066894A (es) | 2006-11-24 |
RU2006138433A (ru) | 2008-05-10 |
KR100830007B1 (ko) | 2008-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR050913A1 (es) | Compuestos derivados de tiazolpiridina como activadores de glucoquinasa; composiciones farmaceuticas que los contienen y su uso en medicamentos para el tratamiento de la diabetes tipo ii | |
AR056548A1 (es) | Derivados de sulfonamidas, composiciones farmaceuticas y sus usos | |
AR061651A1 (es) | Analogos de piridina ii | |
AR043355A1 (es) | Compuestos derivados de amida, preparacion de medicamentos que los contienen para el tratamiento y prevencion de trastornos asociados con glucocorticoides | |
AR037907A1 (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
AR037489A1 (es) | Quinolinas sustituidas y proceso para su preparacion | |
AR035774A1 (es) | Derivados benzimidazol y piridilimidazol, un procedimiento para su preparacion, composiciones farmaceuticas y paquetes que los comprenden, el uso de dichos compuestos solos o en combinacion para la manufactura de medicamentos como ligandos para gabaa, y metodo de tratamiento | |
EA200600364A1 (ru) | Производные (тио)карбамоилциклогексана в качестве антагонистов d/dрецептора | |
AR079690A1 (es) | Derivados heterociclicos de pirrol[2,3-b]piridina, composiciones farmaceuticas que los contienen, procedimiento para prepararlos y uso de los mismos como agentes anticancer. | |
PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
AR029815A1 (es) | Derivados aza-indolicos, un proceso para su preparacion, composicion farmaceutica, un metodo para su elaboracion y el uso de dichos derivados para la manufactura de un medicamento | |
GB0507601D0 (en) | Compounds | |
AR044399A1 (es) | Compuestos heterociclicos y su uso como activadores de receptores de ppar. composiciones farmaceuticas que los contienen | |
UY27336A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
PE20060599A1 (es) | DERIVADOS PIRAZOLO-[3,4-d]-PIRIMIDINA COMO INHIBIDORES DE LA ACTIVIDAD DEL RECEPTOR CANNABINOIDE 1 | |
AR088919A2 (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y uso | |
AR040567A1 (es) | Derivados de 1- heterociclilalquil 3- sulfonilindol o -indazol como ligandos de 5- hidroxitriptamina -6 | |
AR038484A1 (es) | Derivados de piridina y pirimidina | |
AR025735A1 (es) | Compuestos terapeuticos | |
PE20040999A1 (es) | Nuevas pirazolopirimidinas como inhibidores de cinasas dependientes de ciclinas | |
AR035945A1 (es) | Derivados de piperacina, su uso en la preparacion de medicamentos, procedimiento para la preparacion de dichos compuestos, composiciones farmaceuticas que comprenden dichos compuestos, y metodo para preparar dichas composiciones | |
PE20081504A1 (es) | Compuestos de biciclocarboxiamida sustituidos | |
MXPA05007494A (es) | Nuevos compuestos. | |
PE20081152A1 (es) | Azaciclilaminas n-sustituidas como antagonistas de histamina-3 | |
AR054632A1 (es) | ANALOGOS DE PIRIDINA, COMPOSICIONES QUE LOS CONTIENEN Y PROCESOS PARA SU PREPARACIoN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |